 |
Onconova Therapeutics Announces The Initial Dosing Of The First Patient In The U.S. Phase 1 Clinical Trial Of ON 123300Onconova announced that the first patient has been dosed in the U.S. Phase 1 clinical trial of ON 123300, the Company’s proprietary, novel multi-kinase inhibitor Research, News & Market Data on Onconova |
 |
Aurania Reports Elevated Silver-Zinc Has Been Discovered In Outcrop Over 2.7 Kilometres At Tiria-ShimpiaAurania Resources announced that follow-up of a high-grade boulder found in a stream has led to the discovery of silver-zinc mineralization Research, News & Market Data on Aurania Resources |
 |
ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line developmentProMIS Neurosciences announced PMN310 potential best in class antibody candidate for treatment of Alzheimer’s disease |
Stay up to date. Follow us:
 |
 |
 |
 |
 |
 |